The effect of weight on exposure in hepatitis C: Peginterferon alfa-2b and peginterferon alfa-2a

被引：0
|
作者：
Silva, M
Cutler, D
Poo-Ramirez, JL
Wagner, F
Jackson, M
Cullen, C
机构：
来源：
GASTROENTEROLOGY | 2005年 / 128卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A723 / A723
页数：1
相关论文
共 50 条
  • [21] Peginterferon alfa-2a in patients with chronic hepatitis C
    Zeuzem, S
    Feinman, SV
    Rasenack, J
    Heathcote, EJ
    Lai, MY
    Gane, E
    O'Grady, J
    Reichen, J
    Diago, M
    Lin, A
    Hoffman, J
    Brunda, MJ
    NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (23): : 1666 - 1672
  • [22] Peginterferon alfa-2b vs. peginterferon alfa-2a in the treatment of hepatitis C, is there any difference? Reply to issues raised in the Jansen/Reesink editorial
    Silva, Marcelo
    JOURNAL OF HEPATOLOGY, 2007, 46 (02) : 350 - 351
  • [23] Clinical and persistency outcomes in hepatitis C patients treated with peginterfercin alfa-2a or peginterferon alfa-2b plus ribavirin
    Hassanein, Tarek
    Ye, Xin
    Chu, Teng-Chiao
    Brixner, Diana
    GASTROENTEROLOGY, 2008, 134 (04) : A833 - A833
  • [24] Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection (vol 361, pg 580, 2009)
    McHutchison, J. G.
    Lawitz, E. J.
    Shiffman, M. L.
    Muir, A. J.
    Galler, G. W.
    McCone, J.
    Nyberg, L. M.
    Lee, W. M.
    Ghalib, R. H.
    Schiff, E. R.
    Galati, J. S.
    Bacon, B. R.
    Davis, M. N.
    Mukhopadhyay, P.
    Koury, K.
    Noviello, S.
    Pedicone, L. D.
    Brass, C. A.
    Albrecht, J. K.
    Sulkowski, M. S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (10): : 1027 - 1027
  • [25] Treatment persistence in and cost of therapy for patients with chronic hepatitis C: Peginterferon alfa-2a plus ribavirin versus peginterferon alfa-2b plus ribavirin
    Brixner, Diana I.
    Ye, Xin
    Chu, Teng-Chiao
    Blumentals, William A.
    Hassanein, Tarek I.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2009, 66 (24) : 2171 - 2178
  • [26] Peginterferon alfa-2a versus peginterferon alfa-215 in the treatment of chronic hepatitis C.
    Mauss, S
    Berger, F
    Schmutz, G
    HEPATOLOGY, 2004, 40 (04) : 730A - 730A
  • [27] Peginterferon alfa-2a and peginterferon alfa-2b combined with ribavirin in patients with genotype 1 chronic hepatitis C: Results of a prospective single-centre study
    Berak, Hanna
    Laskus, Tomasz
    Kolakowska-Rzadzka, Anna
    Wasilewski, Marek
    Stanczak, Janusz J.
    Bardadin, Krzysztof
    Walewska-Zielecka, Bozena
    Horban, Andrzej
    ADVANCES IN MEDICAL SCIENCES, 2014, 59 (02): : 261 - 265
  • [28] Peginterferon Alfa-2a Is Superior to Peginterferon Alfa-2b in the Treatment of Naive Patients with Hepatitis C Virus Infection: Meta-Analysis of Randomized Controlled Trials
    Singal, Ashwani K.
    Jampana, Sarat C.
    Anand, Bhupinderjit S.
    DIGESTIVE DISEASES AND SCIENCES, 2011, 56 (08) : 2221 - 2226
  • [29] MARKED SPIROMETRY DECLINE IN PATIENTS WITH CHRONIC HEPATITIS C DURING TREATMENT WITH ALBINTERFERON ALFA-2B IS SIMILAR TO PEGINTERFERON ALFA-2A
    Zeuzem, S.
    Sulkowski, M.
    Nelson, D.
    Benhamou, Y.
    Yin, Y.
    Feutren, G.
    Noble, P.
    McHutchison, J.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S130 - S130
  • [30] Peginterferon alfa-2b plus ribavirin for chronic hepatitis
    Cecil, BD
    LANCET, 2002, 359 (9302): : 263 - 264
12345